Research map: MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancer
Back to the article
Papers in this map
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
· Michael I. Love · 2014 · 104531 citations · Cited by this paper
Glucocorticoid signalling exerts distinct lineage-permissive and dose-dependent disruptive actions during human osteoblast differentiation
· Martin R. Madsen · 2026 · Cites this paper
Tailored HER2 ECD mRNA-LNP vaccines boost CD8+ T cell-mediated antitumor immunity for HER2-positive tumor suppression
· 2026 · Related
Trimmomatic: a flexible trimmer for Illumina sequence data
· Anthony Bolger · 2014 · 71940 citations · Cited by this paper
Resistance to CAR-based cell therapy: Mechanisms and overcoming strategies
· 2026 · Related
Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation
· Nuala A. O’Leary · 2015 · 7255 citations · Cited by this paper
Low dose radiation induces new protein synthesis that promotes cancer radiotherapy resistance
· 2026 · Related
DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)
· Brad T. Sherman · 2022 · 6631 citations · Cited by this paper
Long-term outcomes and exploratory analysis from a randomized phase 3 trial of radiation dose escalation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
· 2026 · Related
The hallmarks of cancer metabolism: Still emerging
· Natalya N. Pavlova · 2022 · 1471 citations · Cited by this paper
ZBED6-Driven Nucleotide Metabolic Reprogramming Improves Sensitivity to anti-PD1 Therapy in NK/T Cell Lymphoma
· 2026 · Related
Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality of the reference assembly
· Valérie Schneider · 2017 · 1346 citations · Cited by this paper
PRKCA and ABCB1 dual-enriched exosomes are key drivers of drug resistance in chronic myeloid leukemia
· 2026 · Related
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer
· Ping Mu · 2017 · 1092 citations · Cited by this paper
Mechanistic analysis on epigenetic programming of tumor drug resistance
· 2026 · Related
Biology of Progressive, Castration-Resistant Prostate Cancer: Directed Therapies Targeting the Androgen-Receptor Signaling Axis
· Howard I. Scher · 2005 · 1038 citations · Cited by this paper
Transcription Factor Dynamics in Neuroendocrine Prostate Cancer Development.
· 2025 · Related
Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH
· Jihye Yun · 2015 · 925 citations · Cited by this paper
Reappraisal of Neuroendocrine Tumor Classification of the Prostate Gland: Translating Molecular Insights into Clinical Practice
· 2025 · Related
Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy
· Ali F. Abdel-Wahab · 2019 · 614 citations · Cited by this paper
RNA m 1 A methyltransferase TRMT61A promotes colorectal tumorigenesis by enhancing ONECUT2 mRNA stability and is a potential therapeutic target
· 2025 · Related
Androgen Signaling in Prostate Cancer
· Charles Sichao Dai · 2017 · 418 citations · Cited by this paper
High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
· Dong Lin · 2013 · 373 citations · Cited by this paper
Clinical and Biological Features of Neuroendocrine Prostate Cancer
· Yasutaka Yamada · 2021 · 327 citations · Cited by this paper
Quantitative determinants of aerobic glycolysis identify flux through the enzyme GAPDH as a limiting step
· Alexander A. Shestov · 2014 · 324 citations · Cited by this paper
A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product
· Maria V. Liberti · 2017 · 210 citations · Cited by this paper
Molecular events in neuroendocrine prostate cancer development
· Yong Wang · 2021 · 199 citations · Cited by this paper
FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer
· Ming Han · 2022 · 176 citations · Cited by this paper
Insulin stimulates glyceraldehyde-3-phosphate dehydrogenase gene expression through cis-acting DNA sequences.
· M.C. Alexander · 1988 · 127 citations · Cited by this paper
Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies
· Loredana Puca · 2018 · 123 citations · Cited by this paper
Deregulation of glycolysis in cancer: glyceraldehyde-3-phosphate dehydrogenase as a therapeutic target
· George Sergeevich Krasnov · 2013 · 100 citations · Cited by this paper
Pleiotropic effects of moonlighting glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in cancer progression, invasiveness, and metastases
· Michael A. Sirover · 2018 · 90 citations · Cited by this paper
SOX2 mediates metabolic reprogramming of prostate cancer cells
· Larischa de Wet · 2022 · 76 citations · Cited by this paper
Targeting glycolysis in non-small cell lung cancer: Promises and challenges
· Jiaqi Xu · 2022 · 73 citations · Cited by this paper
Targeting MCT 4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer
· Stephen Yiu Chuen Choi · 2018 · 69 citations · Cited by this paper
Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in late pathological stage human prostate cancer
· RH Rondinelli · 1997 · 64 citations · Cited by this paper
Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression
· Erhu Fang · 2020 · 64 citations · Cited by this paper
ADT with antiandrogens in prostate cancer induces adverse effect of increasing resistance, neuroendocrine differentiation and tumor metastasis
· Yuanjie Niu · 2018 · 63 citations · Cited by this paper
Glucose-dependent active ATP depletion by koningic acid kills high-glycolytic cells
· Shohei Kumagai · 2007 · 58 citations · Cited by this paper
Source: OpenAlex (CC0)